參考文獻(xiàn)/References:
[1] Wysokinski WE,McBane RD,Daniels PR,et al.Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation[J].Mayo Clinic Proc,2008,83(6):639-645.
[2] James D,Alex C,Frederick A,et al.Perioperative management of antithrombotic therapy:Antithrnmbotic therapy and prevention of thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].2012,141(2 suppl):326-350.
[3] Kovacs MJ,Kearon C,Rodger M,et al.Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin[J].Circulation,2004,110(12):1658-1663.
[4] Larson BJ,Zumberg MS,Kitchens CS.A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk[J].Chest,2005,127(3):922-927.
[5] Douketis JD,Johnson JA,Turpie AG.Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin:assessment of a standardized periprocedural anticoagulation regimen[J].Arch Intern Med,2004,164(12):1319-1326.
[6] 張孝靜,傅武平.老年髖部骨折術(shù)后抗凝治療的臨床觀察及護(hù)理[J].中醫(yī)正骨,2013,25(5):76.
[7] 萬華,羅漫麗,魏潤玲.股骨近端防旋髓內(nèi)釘治療合并阿爾茨海默病的股骨轉(zhuǎn)子間骨折的圍手術(shù)期護(hù)理[J].中醫(yī)正骨,2014,26(1):77-78.
[8] Ansell J,Hirsh J,Hylek E,et al.Pharmacology and management of the vitamin K antagonists:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition)[J].Chest,2008,133(6 Suppl):160-198.
相似文獻(xiàn)/References:
[1]易春智,陳錦倫,李肇宏,等.利伐沙班與依諾肝素鈉對髖膝關(guān)節(jié)置換術(shù)后
下肢深靜脈血栓形成及圍手術(shù)期隱性失血的影響[J].中醫(yī)正骨,2016,28(01):17.
YI Chunzhi,CHEN Jinlun,LI Zhaohong,et al.Influence of Rivaroxaban and enoxaparin sodium on lower extremity deep venous thrombosis after total hip&knee arthroplasty and perioperative hidden blood loss[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):17.
[2]何雪花.快速康復(fù)外科理念在膝關(guān)節(jié)鏡手術(shù)圍手術(shù)期護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2017,29(02):79.